Business Brief -- Atrix Laboratories Inc.:
   Concern Delays Application
   To FDA for Further Study
A spokesman wouldn't elaborate on the studies, except to
say that they may focus on the design of the Phase III tests.
   Atrix, a research and development firm in the area of
therapeutic products, also said that it purchased the rights
to a biodegradable drug delivery technology from Southern
Research Institute, Birmingham, Ala., for just over $4
million. It also said it signed a research and development
and supply agreement with Colgate-Palmolive Co. to develop a
dental product and reached a development agreement with
Upjohn Co. to study a drug delivery system for animal health
care products.